Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

DJ US Pharmaceuticals Ishares (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 569,846,000
  • Shares Outstanding, K 3,550

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.87 +3.63%
on 12/20/17
162.10 -1.63%
on 01/16/18
+3.59 (+2.30%)
since 12/15/17
3-Month
147.70 +7.96%
on 11/15/17
162.10 -1.63%
on 01/16/18
+2.46 (+1.57%)
since 10/16/17
52-Week
137.16 +16.25%
on 01/31/17
162.10 -1.63%
on 01/16/18
+14.49 (+10.00%)
since 01/13/17

Most Recent Stories

More News
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 45.29 (-0.98%)
JNJ : 146.86 (+0.75%)
MRK : 62.07 (+5.81%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
LLY : 85.29 (-1.94%)
PPH : 62.76 (-0.16%)
PFE : 36.60 (+0.16%)
BMY : 59.92 (-4.60%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 45.29 (-0.98%)
JNJ : 146.86 (+0.75%)
MRK : 62.07 (+5.81%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
LLY : 85.29 (-1.94%)
PPH : 62.76 (-0.16%)
PFE : 36.60 (+0.16%)
BMY : 59.92 (-4.60%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 45.29 (-0.98%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
PPH : 62.76 (-0.16%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 45.29 (-0.98%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
PPH : 62.76 (-0.16%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 45.29 (-0.98%)
JNJ : 146.86 (+0.75%)
MRK : 62.07 (+5.81%)
IHE : 159.45 (-0.60%)
PJP : 67.62 (-0.47%)
LLY : 85.29 (-1.94%)
PFE : 36.60 (+0.16%)
BMY : 59.92 (-4.60%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 45.29 (-0.98%)
JNJ : 146.86 (+0.75%)
MRK : 62.07 (+5.81%)
IHE : 159.45 (-0.60%)
PJP : 67.62 (-0.47%)
LLY : 85.29 (-1.94%)
PFE : 36.60 (+0.16%)
BMY : 59.92 (-4.60%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 87.25 (+0.50%)
VHT : 162.09 (+0.15%)
JNJ : 146.86 (+0.75%)
IHE : 159.45 (-0.60%)
IYH : 183.14 (+0.34%)
FHLC : 42.09 (+0.21%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 87.25 (+0.50%)
VHT : 162.09 (+0.15%)
JNJ : 146.86 (+0.75%)
IHE : 159.45 (-0.60%)
IYH : 183.14 (+0.34%)
FHLC : 42.09 (+0.21%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 45.29 (-0.98%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
PPH : 62.76 (-0.16%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 45.29 (-0.98%)
PJP : 67.62 (-0.47%)
IHE : 159.45 (-0.60%)
PPH : 62.76 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 163.20
1st Resistance Point 161.32
Last Price 159.45
1st Support Level 158.35
2nd Support Level 157.25

See More

52-Week High 162.10
Last Price 159.45
Fibonacci 61.8% 152.57
Fibonacci 50% 149.63
Fibonacci 38.2% 146.69
52-Week Low 137.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.